Overview

CD ComputaBio is a leading provider of innovative drug reposition solutions that help pharmaceutical companies and research organizations repurpose existing drugs for new therapeutic indications. Our comprehensive suite of services combines advanced algorithms, cutting-edge technology, and deep expertise in drug discovery and development to unlock the hidden potential of drugs and accelerate the process of bringing new therapies to market.

Our Services

• Target Identification

Our experienced team of scientists and bioinformaticians use their extensive knowledge of genomics, proteomics and drug databases to identify promising targets for drug reposition. By integrating multiple data sources and using sophisticated algorithms, we can identify high-potential targets with minimal side effects and validate their therapeutic relevance.

• Virtual Screening

We utilize state-of-the-art computational tools and in silico models to virtually screen databases containing information on approved drugs, clinical candidates, and natural compounds. This approach allows us to rapidly assess drug-target interactions, predict potential off-target effects, and prioritize compounds with the highest chance of success.

• Computational Analytics

Our computational analysis services encompass a wide range of techniques, including molecular docking, molecular dynamics simulations, machine learning algorithms, and network pharmacology. By combining these approaches, we can identify novel biological pathways, understand the mechanism of action, and predict the efficacy and safety of drug candidates.

Applications

• Oncology: Identifying potential anti-cancer properties in existing drugs and uncovering novel combinations for enhanced efficacy in cancer treatment.
• Infectious Diseases: Rediscovering known drugs with antiviral or antibacterial properties, helping to combat emerging infectious diseases and drug-resistant pathogens.
• Neurological Disorders: Uncovering reposition opportunities to address neurodegenerative diseases and psychiatric disorders.

Algorithms

• Molecular Similarity Analysis: Utilizes advanced molecular fingerprinting and similarity metrics to identify drugs with similar structural and pharmacological profiles, thereby discovering reposition candidates with common biological activities.
• Network Analysis: A network-based approach to unravel the intricate interactions between drugs, targets, and diseases to gain a comprehensive understanding of potential reposition opportunities in molecular interaction networks.
• Machine Learning Models: Machine learning algorithms are used to build predictive models for drug reposition and generate accurate and reliable predictions of reposition potential using a variety of data sources.

Sample Requirements

To carry out our drug reposition services effectively, we require the following sample information:

• Approved drugs, clinical candidate molecules, or natural compounds of interest.
• Biological targets, pathways, or diseases for reposition.
• Relevant experimental data, such as binding affinity or activity assays, if available.

Deliverables

Upon completion of our drug reposition services, CD ComputaBio provides clients with a comprehensive report that includes:

• List of potential drugs for reposition, along with their target interactions and predicted efficacy.
• Detailed insights into the mechanism of action and potential off-target effects.
• Computational predictions of safety and toxicity profiles.
• Recommendations for further experimental validation and clinical development.

Why Choose Us?

Frequently Asked Questions

Name *

Phone

Email *

Products/Services Interested *

Project Description

Submit